on
2nd International Conference and Exhibition on Biowaivers and Biosimilars
September 23-25, 2013 Hilton, Raleigh, North Carolina, USA
Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs BLOG CONTACT
Biosimilars-2013
Home
Gallery
Biosimilars-2013 Report

Biosimilars-2013 Report

2nd International Conference and Exhibition on Biowaivers & Biosimilars was successfully organized by OMICS Group on September 23-25, 2013 at Raleigh, North Carolina, USA. Outstanding response and active participation was received from the researchers, leaders from regulatory, pharmaceutical R&D sectors, and principal investigators. Organizing Committee Members & Editorial Board Members of OMICS Group helped in making this meeting a grand success.

The theme of this event “Addressing Novel Strategic Considerations for Biosimilar Market” covered a broad range of vitally important sessions that covered the way to exchange ideas and perspectives on the challenges in this field.

The conference proved to be the most important gathering for Pharma leaders, in competing to bring affordable medicines to market and establishment of insightful case studies and in-depth market analysis for the fast-growing of Biosimilars.  

Keynote sessions were preceded by eminent speakers:

Dr. Michael Retsky, Harvard School of Public Health, USA
Dr. Ivo Abraham, University of Arizona, USA
Dr. Russell Reeve, Quintiles Inc., USA
Dr. Arturo Solis Herrera, Human Photosynthesis Study Center, Mexico
Dr. Rodeina Challand, PRA International, UK

OMICS Group International conveys its wishes for the support of various organizations and delegates from all around the world. And our sincere admiration to our Event exhibitor: FeF Chemicals for their determined efforts towards manufacturing and supply high purity products, and BioPort Folio (USA), ChemLinked (China) & Lab Bulletin (USA) for its efforts in promoting this event throughout its network.

With grand success of Biosimilars-2013 in USA, OMICS Group International is proud to announce "3rd International Conference and Exhibition on Biowaivers & Biosimilars” during October 27-29, 2014 in Hyderabad, India.

Coming together is a beginning; keeping together is progress; working together is success.

We wish to lead a way to a fabulous event.

 



Expert Presentations
Michael Retsky

Harvard School of Public Health

USA
Ivo Abraham

University of Arizona

USA
Russell Reeve

Quintiles Inc.

USA
Jichao (Jay) Kang

Laureate Biopharmaceutical Services

USA
Jeff Lyons

Absorption Systems

USA
Sailesh Patel

Schiff Hardin LLP

USA
Kevin W. McCabe

Sterne, Kessler, Goldstein & Fox

USA
Adriana E. Manzi

Atheln, Inc

USA
Deborah Thibodeaux

DKT Lab Consulting

USA
Alok Bandyopadhyay

Design Space Inpharmatics

USA
Fiona Greer

SGS M-Scan

UK
Rodeina Challand

PRA International

UK
Ciriaco Maraschiello

Harlan Laboratories Inc

USA
Brian R. Dorn

Barnes & Thornburg LLP

USA
Arturo Solis Herrera

Human Photosynthesis Study Center

Mexico
Michiel E. Ultee

Laureate Biopharmaceutical Services, Inc.

USA
Kent Pryor

ZZ Biotech

USA
Subhash Basu

University of Notre Dame

USA
Daniel Galbraith

BioOutsource Ltd

UK
Jennifer Campbell

Merck Millipore

France
Steven Lehrer

Optimal Strategix Group

USA
Marguarite Mensonides-Harsema

Medac GmbH

Germany
Oliver Zimmermann

Cardiovascular Center Oberallgau-Kempten

Germany
Yunsheng Hsieh

Protech Pharmaservices Corporation

Taiwan
Martin Gleeson

Genalyte

USA
Ajay K. Banga

Mercer University

USA
Conference Secretariat: Biosimilars-2013, Conference Series Conferences
47 Churchfield Road, London, W3 6AY, UK,
Tel: +44-800-014-8923 , Fax: +44-203-004-1517
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
Operated by: Editors - Journal of Bioanalysis & Biomedicine, Journal of Bioequivalence & Bioavailability and Journal of Pharmaceutical Sciences & Emerging Drugs
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2008-2012 Conference Series - All rights reserved